MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

DaVita HealthCare Partners Company Profile (NYSE:DVA)

Consensus Ratings for DaVita HealthCare Partners (NYSE:DVA) (?)
Ratings Breakdown: 4 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $77.17 (0.02% upside)

Analysts' Ratings History for DaVita HealthCare Partners (NYSE:DVA)
Show:
DateFirmActionRatingPrice TargetActions
5/8/2016Robert W. BairdReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016SusquehannaBoost Price TargetNeutral$70.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/4/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2016Sanford C. BernsteinLower Price TargetMarket Perform$74.50 -> $71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/16/2016RBC CapitalLower Price TargetSector Perform$80.00 -> $71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2016William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2016Piper JaffrayReiterated RatingOverweight$90.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Goldman SachsLower Price Target$80.00 -> $76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015JPMorgan Chase & Co.Boost Price TargetNeutral$82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015Deutsche BankBoost Price TargetHold$78.00 -> $83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2014KeyBancDowngradeBuy -> Hold$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2014Raymond JamesDowngradeOutperform -> Market Perform$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha